The Ensign Group, Inc. logo

The Ensign Group, Inc.

ENSG

NASDAQHealthcareMedical - Care Facilities

Previous close

$179.48

−$0.37 · -0.21%

Aug 21, 4:00 PM ET

ENSG company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

32

Expensive

Momentum

38

Weakening

Sentiment

41

Mixed

Risk resilience

63

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

The Ensign Group, Inc. operates as a healthcare provider, primarily concentrating on post-acute care services, alongside other supporting business ventures. The company's activities are organized into two main divisions: Skilled Services and Real Estate. Within its Skilled Services segment, Ensign provides extensive short-term and long-term nursing care tailored for patients recovering from extended illnesses, managing chronic health conditions, or requiring elder care. This division also encompasses a variety of rehabilitative therapies, such as physical, occupational, and speech therapy, among other specialized healthcare provisions. Beyond direct medical care, the company furnishes essential amenities like lodging, customized dietary programs, and opportunities for social engagement, recreation, and entertainment. Ensign additionally manages senior living facilities and delivers convenient mobile diagnostic services. Its diverse array of supplementary services includes digital X-rays, ultrasounds, electrocardiograms, laboratory analyses, sub-acute care, and patient transportation, which can be provided either in patients' residences or at long-term care facilities. The company also engages in the leasing of real estate properties. As of April 4, 2022, Ensign operated a network of 252 healthcare facilities spread across thirteen U.S. states: Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The Ensign Group, Inc. was established in 1999 and is headquartered in San Juan Capistrano, California.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
Barry R. Port
Listed since
Nov 9, 2007
Employees
46,000

Market position

Day range

Current $179.48

52-week range

Current $179.48

Open
$180.36
Previous close
$179.85
Volume
280.97K
0.41× average
Average volume
683.63K
Average daily volume
Market cap
10.46B USD
Beta
0.69
Market reference 1
50-day average
$170.6
+5.21% above average
200-day average
$182.66
-1.74% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
13.63B USD
P/E (TTM)
27.32×
P/B (TTM)
4.26×
P/S (TTM)
1.91×
EV / EBITDA
24.01×
Earnings yield
3.45%
Free cash flow yield
3.71%
Dividend yield
0.14%

Profitability & efficiency

Gross margin
14.14%
Operating margin
8.52%
Net margin
6.90%
Return on equity
15.41%
Return on assets
6.30%
Return on invested capital
6.86%

Financial health

Debt / equity
0.92×
Current ratio
1.42×
Altman Z-score
3.66
Piotroski F-score
7 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends19%14%9%4%Gross margin, FY2021: 17.82%Gross margin, FY2022: 17.12%Gross margin, FY2023: 15.84%Gross margin, FY2024: 15.67%Gross margin, FY2025: 15.81%Operating margin, FY2021: 9.91%Operating margin, FY2022: 9.81%Operating margin, FY2023: 6.85%Operating margin, FY2024: 8.41%Operating margin, FY2025: 8.41%Net margin, FY2021: 7.41%Net margin, FY2022: 7.43%Net margin, FY2023: 5.61%Net margin, FY2024: 6.99%Net margin, FY2025: 6.80%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 17.82%. Gross margin FY2022 17.12%. Gross margin FY2023 15.84%. Gross margin FY2024 15.67%. Gross margin FY2025 15.81%. Operating margin FY2021 9.91%. Operating margin FY2022 9.81%. Operating margin FY2023 6.85%. Operating margin FY2024 8.41%. Operating margin FY2025 8.41%. Net margin FY2021 7.41%. Net margin FY2022 7.43%. Net margin FY2023 5.61%. Net margin FY2024 6.99%. Net margin FY2025 6.80%.

Income trends

Revenue

5.06B USD+18.72%

Operating income

425.31M USD+18.70%

Net income

343.97M USD+15.44%
Income trends across reported periods5.54B USD3.6B USD1.65B USD−291.67M USDRevenue, FY2021: 2.63B USDRevenue, FY2022: 3.03B USDRevenue, FY2023: 3.73B USDRevenue, FY2024: 4.26B USDRevenue, FY2025: 5.06B USDOperating income, FY2021: 260.47M USDOperating income, FY2022: 296.83M USDOperating income, FY2023: 255.37M USDOperating income, FY2024: 358.3M USDOperating income, FY2025: 425.31M USDNet income, FY2021: 194.65M USDNet income, FY2022: 224.68M USDNet income, FY2023: 209.4M USDNet income, FY2024: 297.97M USDNet income, FY2025: 343.97M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 2.63B USD. Revenue FY2022 3.03B USD. Revenue FY2023 3.73B USD. Revenue FY2024 4.26B USD. Revenue FY2025 5.06B USD. Operating income FY2021 260.47M USD. Operating income FY2022 296.83M USD. Operating income FY2023 255.37M USD. Operating income FY2024 358.3M USD. Operating income FY2025 425.31M USD. Net income FY2021 194.65M USD. Net income FY2022 224.68M USD. Net income FY2023 209.4M USD. Net income FY2024 297.97M USD. Net income FY2025 343.97M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue5.06B USD4.26B USD3.73B USD3.03B USD2.63B USD
Cost of goods sold4.26B USD3.59B USD3.14B USD2.51B USD2.16B USD
Gross profit799.45M USD667.59M USD590.76M USD517.99M USD468.21M USD
Selling, general, and administrative269.82M USD225.14M USD263.01M USD158.81M USD151.76M USD
Operating expenses374.15M USD309.28M USD335.39M USD221.16M USD207.75M USD
Interest income24.51M USD28.75M USD19.22M USD5.04M USD4.39M USD
Interest expense7.99M USD8.29M USD8.09M USD8.93M USD6.85M USD
Depreciation and amortization104.33M USD84.14M USD72.39M USD62.36M USD55.99M USD
Operating income425.31M USD358.3M USD255.37M USD296.83M USD260.47M USD
Net income343.97M USD297.97M USD209.4M USD224.68M USD194.65M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
100%
11 beats, 0 misses, 0 met estimates
Average EPS surprise
+2.29%
11 comparable reports
Latest EPS result
1.92
Estimate 1.8 · Beat by 6.67%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates21.81.591.39Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 5, 2025: actual 1.49, estimate 1.47, surprise +1.36%, Beat. Q2 2025, reported Apr 29, 2025: actual 1.52, estimate 1.49, surprise +2.01%, Beat. Q3 2025, reported Jul 24, 2025: actual 1.59, estimate 1.55, surprise +2.58%, Beat. Q4 2025, reported Nov 3, 2025: actual 1.64, estimate 1.59, surprise +3.14%, Beat. Q1 2026, reported Feb 4, 2026: actual 1.82, estimate 1.75, surprise +4.00%, Beat. Q2 2026, reported Apr 30, 2026: actual 1.85, estimate 1.82, surprise +1.65%, Beat. Q3 2026, reported Jul 27, 2026: actual 1.92, estimate 1.8, surprise +6.67%, Beat. Q4 2026, reported Nov 2, 2026: actual —, estimate 1.92, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.57B1.4B1.24B1.07BQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 5, 2025: actual 1.13B USD, estimate 1.13B USD, surprise +0.26%, Beat. Q2 2025, reported Apr 29, 2025: actual 1.17B USD, estimate 1.17B USD, surprise +0.06%, Beat. Q3 2025, reported Jul 24, 2025: actual 1.23B USD, estimate 1.22B USD, surprise +0.65%, Beat. Q4 2025, reported Nov 3, 2025: actual 1.3B USD, estimate 1.37B USD, surprise -5.22%, Miss. Q1 2026, reported Feb 4, 2026: actual 1.36B USD, estimate 1.37B USD, surprise -0.52%, Miss. Q2 2026, reported Apr 30, 2026: actual 1.39B USD, estimate 1.4B USD, surprise -0.49%, Miss. Q3 2026, reported Jul 27, 2026: actual 1.44B USD, estimate 1.44B USD, surprise -0.08%, Miss. Q4 2026, reported Nov 2, 2026: actual —, estimate 1.51B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

13 ratings
Strong buy00%
Buy969%
Hold215%
Sell215%
Strong sell00%

ENSG news

ENSG peers

ETFs holding ENSG

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research ENSG

research.disclaimer